Anti-inflammatory medications and coronary artery disease

被引：0
|
作者：
Jindal, Charulata [1 ]
Buch, Ashesh N. [2 ]
Efird, Jimmy T. [3 ]
机构：
[1] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia
[2] East Carolina Univ, Brody Sch Med, East Carolina Heart Inst, Dept Cardiovasc Sci, Greenville, NC 27858 USA
[3] Duke Univ, Cooperat Studies Program Epidemiol Ctr, Hlth Serv Res & Dev, Affiliated Ctr, Durham, NC 27706 USA
来源：
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY | 2021年 / 28卷 / 02期
关键词：
C-REACTIVE PROTEIN; HEALTHY LIFE-STYLE; PRIMARY PREVENTION; CARDIOVASCULAR-DISEASE; HEART-DISEASE; INFLAMMATION; WOMEN; ATHEROSCLEROSIS; ASPIRIN; GENDER;
D O I：
10.1177/2047487319889719
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：149 / 151
页数：3
相关论文
共 50 条
  • [31] Lipid-lowering and anti-inflammatory effect of ezetimibe in hyperlipidemic patients with coronary artery disease
    Tetsuya Tobaru
    Atsushi Seki
    Ryuta Asano
    Tetsuya Sumiyoshi
    Nobuhisa Hagiwara
    Heart and Vessels, 2013, 28 : 39 - 45
  • [32] Role of Vascular Inflammation in Coronary Artery Disease: Potential of Anti-inflammatory Drugs in the Prevention of Atherothrombosis
    Moreira, Daniel Medeiros
    da Silva, Roberto Leo
    Vieira, Jefferson Luis
    Fattah, Tammuz
    Lueneberg, Maria Emilia
    Mascia Gottschall, Carlos Antonio
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2015, 15 (01) : 1 - 11
  • [33] Decreased circulating catestatin levels are associated with coronary artery disease: The emerging anti-inflammatory role
    Chen, Yanjia
    Wang, Xiaoqun
    Yang, Chendie
    Su, Xiuxiu
    Yang, Wenbo
    Dai, Yang
    Han, Hui
    Jiang, Jie
    Lu, Lin
    Wang, Haibo
    Chen, Qiujing
    Jin, Wei
    ATHEROSCLEROSIS, 2019, 281 : 78 - 88
  • [34] Lipid-lowering and anti-inflammatory effect of ezetimibe in hyperlipidemic patients with coronary artery disease
    Tobaru, Tetsuya
    Seki, Atsushi
    Asano, Ryuta
    Sumiyoshi, Tetsuya
    Hagiwara, Nobuhisa
    HEART AND VESSELS, 2013, 28 (01) : 39 - 45
  • [35] Alternative anti-inflammatory and immunomodulator medications for asthma
    Stempel, DA
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 1999, 19 (04) : 855 - +
  • [36] Anti-Inflammatory Therapy and Coronary Artery Calcification Over Time REPLY
    Lee, Sang-Eun
    Berman, Daniel S.
    Chang, Hyuk-Jae
    JACC-CARDIOVASCULAR IMAGING, 2018, 11 (10) : 1553 - 1553
  • [37] Lack of anti-inflammatory and anti-oxidative effects of chronic treatment with clopidogrel in patients with stable coronary artery disease
    Ostad, M. A.
    Nick, E.
    Paixao-Gatinho, V.
    Schnorbus, B.
    Schiewe, R.
    Tschentscher, P.
    Munzel, T.
    Warnholtz, A.
    EUROPEAN HEART JOURNAL, 2010, 31 : 547 - 547
  • [38] CARDIAC EFFECTS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH CORONARY-ARTERY DISEASE
    TIERNEY, WM
    WELLS, PJ
    MCDONALD, CJ
    CLINICAL RESEARCH, 1984, 32 (02): : A657 - A657
  • [39] Inflammation and coronary artery disease: from pathophysiology to Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS)
    Ali, Mahboob
    Girgis, Sameh
    Hassan, Atif
    Rudick, Steven
    Becker, Richard C.
    CORONARY ARTERY DISEASE, 2018, 29 (05) : 429 - 437
  • [40] Association of platelet reactivity and endothelial function and anti-inflammatory effects in patients with stable coronary artery disease
    Kim, W.
    Kim, H. S.
    Woo, J. S.
    Kim, J. B.
    Kim, W. S.
    EUROPEAN HEART JOURNAL, 2013, 34 : 1011 - 1011
12345